TISSUE INHIBITOR OF METALLOPROTEINASE 1, MATRIX METALLOPROTEINASE 9, ALPHA-1 ANTITRYPSIN, METALLOTHIONEIN AND UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN SKIN BIOPSIES FROM PATIENTS AFFECTED BY AUTOIMMUNE BLISTERING DISEASES

TISSUE INHIBITOR OF METALLOPROTEINASE 1, MATRIX METALLOPROTEINASE 9, ALPHA-1 ANTITRYPSIN, METALLOTHIONEIN AND UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN SKIN BIOPSIES FROM PATIENTS AFFECTED BY AUTOIMMUNE BLISTERING DISEASES

Introduction: Proteinases and proteinase inhibitors have been described to play a role in autoimmune skin blistering diseases. We studied skin lesional biopsies from patients affected by several autoimmune skin blistering diseases for proteinases and proteinase inhibitors. Methods: We utilized immun...

Full description

Bibliographic Details
Main Authors: Ana Maria Abreu Velez, Maria Mercedes Yepes Naranjo, Isabel Cristina Avila, Martha Luz Londoño, Paul B. Googe Jr., Jorge Enrique Velásquez Velez, Ivan Dario Velez, Yulieth Alexandra Upegui, Alejandra Jimenez-Echavarria, Natalia Regina Mesa-Herrera, Hong Yi, Juliana Calle-Isaza, Michael S. Howard
Format: Article
Language:English
Published: Our Dermatology Online 2013-07-01
Series:Nasza Dermatologia Online
Subjects:
endemic pemphigus foliaceus
autoimmune blistering skin diseases
matrix metalloproteinase 9
tissue inhibitor of metalloproteinases 1
urokinase type plasminogen activator receptor
alpha-1-antitrypsin.
Online Access:http://www.odermatol.com/issue-in-html/2013-3-3-tissue/

Internet

http://www.odermatol.com/issue-in-html/2013-3-3-tissue/

Similar Items